| Literature DB >> 30804411 |
Michiko Toizumi1,2, Masahiro Hashizume1,2, Hien Anh T Nguyen3, Michio Yasunami4,5, Noriko Kitamura1, Chihiro Iwasaki1, Mizuki Takegata1, Hiroyuki Moriuchi2,6, Duc Anh Dang3, Koya Ariyoshi2,5, Lay-Myint Yoshida7,8.
Abstract
Few studies have investigated possible causative and protective factors associated with allergic diseases in resource-limited countries, Southeast Asia. We estimated the current prevalence of asthma, rhinoconjunctivitis, and eczema among 6-year-old children, and identified anthropometric factors associated with asthma, rhinoconjunctivitis and eczema, in South-Central Vietnam. A birth cohort study recruited 1,999 children born at a provincial hospital in Nha Trang, Vietnam between May 2009 and May 2010. A 6-year follow-up survey was conducted where clinical, familial, and environmental information was collected by interviewing caregivers using a standardized form based on the International Study of Asthma and Allergies in Childhood, Phase Three Core and Environmental Questionnaire for 6-7-year-old children. The odds ratios of asthma, rhinoconjunctivitis, and eczema for anthropometric factors were estimated using logistic regression analysis. In total, 1202 children participated in the follow-up survey. The proportions of children who had current asthma, rhinoconjunctivitis, and eczema were 5.1% (95% confidence interval [CI] 3.9-6.5%), 11.5% (9.7-13.4%), and 6.7% (5.3-8.2%), respectively. Low birthweight (adjusted odds ratio 5.12, 95% CI 1.92-13.64) was independently associated with increased risk of eczema. Further studies are necessary to understand the involved mechanism.Entities:
Year: 2019 PMID: 30804411 PMCID: PMC6389945 DOI: 10.1038/s41598-019-39658-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Details of the enrollment and follow-up of the study participants.
Characteristics of the children who participated in the six-year follow-up survey.
| Characteristics (n = 1202) | Number (%)/ mean (standard deviation) | ||
|---|---|---|---|
|
| |||
| Sex | Male | 610 (50.8) | |
| Female | 592 (49.3) | ||
| Age (years old) | 6.7 (0.2) | ||
| Body weight (kg) | 25.9 (5.8) | ||
| Body weight | |||
| 25 kg or more | 568 (47.3) | ||
| less than 25 kg | 634 (52.8) | ||
| Body height (cm) | 119.7 (5.9) | ||
|
| |||
| Mode of delivery | |||
| Vaginal | 688 (57.2) | ||
| Caesarean section | 514 (42.8) | ||
| Birthweight (g) | 3267.9 (411.5) | ||
| Birthweight | |||
| >=2500 g | 1175 (97.8) | ||
| <2500 g | 27 (2.3) | ||
| Gestational age at birth (weeks) | 39.6 (1.2) | ||
| Gestational age at birth | |||
| >=37 weeks | 1166 (97.0) | ||
| <37 weeks | 36 (3.0) | ||
| Light-for-dates | 129 (10.7) | ||
|
| |||
| Mother’s age at child’s birth | |||
| 24 years or less | 312 (26.0) | ||
| 25–34 years | 728 (60.6) | ||
| 35 years or more | 162 (13.5) | ||
| (n = 1201) | Maternal history of asthma and allergic diseases | ||
| Yes | 96 (8.0) | ||
| No | 1105 (92.0) | ||
| (n = 1201) | Maternal history of asthma | ||
| Yes | 12 (1.0) | ||
| No | 1189 (99.0) | ||
| (n = 1201) | Maternal history of atopic eczema | ||
| Yes | 13 (1.1) | ||
| No | 1188 (98.9) | ||
| (n = 1201) | Maternal history of rhinitis | ||
| Yes | 76 (6.3) | ||
| No | 1125 (93.7) | ||
| (n = 1191) | Paternal history of asthma and allergic diseases | ||
| Yes | 47 (4.0) | ||
| No | 1144 (96.1) | ||
| (n = 1191) | Paternal history of asthma | ||
| Yes | 9 (0.8) | ||
| No | 1182 (99.2) | ||
| (n = 1191) | Paternal history of atopic eczema | ||
| Yes | 5 (0.4) | ||
| No | 1186 (99.6) | ||
| (n = 1191) | Paternal history of rhinitis | ||
| Yes | 33 (2.8) | ||
| No | 1158 (97.2) | ||
| (n = 1201) | Maternal education level | ||
| No or primary school | 152 (12.7) | ||
| Secondary school | 403 (33.5) | ||
| High school | 399 (33.2) | ||
| College or university | 248 (20.6) | ||
|
| |||
| Number of siblisngs | |||
| 0 | 276 (23.0) | ||
| 1 | 781 (65.0) | ||
| 2 | 112 (9.3) | ||
| 3+ | 33 (2.8) | ||
| Vigorous physical activity | |||
| Never or occasionally | 1023 (85.1) | ||
| Once or twice per week | 130 (10.8) | ||
| Three or more times a week | 49 (4.1) | ||
| Watch television | |||
| Less than 1 hour | 199 (16.6) | ||
| 1 hour but less than 3 hours | 672 (55.9) | ||
| 3 hours but less than 5 hours | 189 (15.7) | ||
| 5 hours or more | 142 (11.8) | ||
| Fuel for cooking | |||
| Electricity | 84 (7.0) | ||
| Gas | 1078 (89.7) | ||
| Open fires | 7 (0.6) | ||
| Others | 33 (2.8) | ||
| Paracetamol use in the first 12 months of life | |||
| Yes | 1049 (87.3) | ||
| No | 153 (12.7) | ||
| Paracetamol use in the past 12 months | |||
| Never | 267 (22.2) | ||
| at least once a year | 767 (63.8) | ||
| at least once per month | 168 (14.0) | ||
| Antibiotics in the first 12 months | |||
| Yes | 876 (72.9) | ||
| No | 326 (27.1) | ||
| Trucks pass through the street | |||
| Never | 512 (42.6) | ||
| Seldom | 324 (27.0) | ||
| Frequently through the day | 279 (23.2) | ||
| Almost the whole day | 87 (7.2) | ||
| Breast feeding | |||
| Yes | 1.152 (95.8) | ||
| No | 50 (4.2) | ||
| Cat or dog in home in the first year of life | |||
| Yes | 333 (27.7) | ||
| No | 869 (72.3) | ||
| Cat or dog in home in the past 12 months | |||
| Yes | 335 (27.9) | ||
| No | 967 (72.1) | ||
| Contact with farm animals in the first year of life | |||
| Yes | 77 (6.4) | ||
| No | 1125 (93.6) | ||
| Mother regular contact with farm animals | |||
| Yes | 110 (9.2) | ||
| No | 1092 (90.9) | ||
| Living in urban communes | |||
| Yes | 768 (63.9) | ||
| No | 434 (36.1) | ||
| Mother smoke | |||
| Yes | 6 (0.5) | ||
| No | 1196 (99.5) | ||
| Mother smoke during child’s first year of life | |||
| Yes | 7 (0.6) | ||
| No | 1195 (99.4) | ||
| Father smoke | |||
| Yes | 629 (52.3) | ||
| No | 573 (47.7) | ||
| Father smoke during mother’s pregnancy | |||
| Yes | 684 (56.9) | ||
| No | 518 (43.1) | ||
| Smoker(s) in household | |||
| Yes | 685 (57.0) | ||
| No | 517 (43.0) | ||
Asthma, rhinoconjunctivitis, and eczema among the children who participated in the six-year follow-up survey.
| Variable | Number | Prevalence (%) |
|---|---|---|
| Wheeze ever | 136 | 11.3 |
| Wheeze in the past 12 months | 61 | 5.1 |
| 4 or more attacks of wheeze in the past 12 months | 12 | 1.0 |
| Sleep disturbance from wheeze, 1 or more nights a week in the past 12 months | 4 | 0.3 |
| Speech limited by wheeze in the past 12 months | 4 | 0.3 |
| Asthma ever | 38 | 3.2 |
| Wheeze during or after exercise in the past 12 months | 18 | 1.5 |
| Night cough in the past 12 months | 156 | 13.0 |
|
|
|
|
| Nose symptoms ever | 573 | 47.7 |
| Nose symptoms in the past 12 months | 409 | 34.0 |
| Nose and eye symptoms in the past 12 months | 138 | 11.5 |
| Nose symptoms affecting activities a lot in the past 12 months | 10 | 0.8 |
| Hay fever ever | ― | ― |
|
|
|
|
| Rash ever | 126 | 10.5 |
| Rash in the past 12 months | 94 | 7.8 |
| Flexural rash | 80 | 6.7 |
| Complete clearance of rash in the past 12 months | 68 | 5.7 |
| Sleep disturbance from rash, 1 or more nights a week in the past 12 months | 4 | 0.3 |
| Eczema ever | 19 | 1.6 |
|
|
|
|
| Number of participants | 1202 |
Risk factor analysis of asthma, rhinoconjunctivitis, and eczema.
| Characteristics (n = 1202) | Number (%) | Asthma, aORa (95% CI) | Rhinoconjunctivis aORa (95% CI) | Eczema, aORa (95% CI) | ||
|---|---|---|---|---|---|---|
|
| ||||||
| Sex | Male | 610 (50.8) | 1.05 (0.62–1.78) | 1.11 (0.78–1.60) | 1.60 (0.99–2.58) | |
| Female | 592 (49.3) | 1.00 | 1.00 | 1.00 | ||
|
| ||||||
| Birthweight | ||||||
| <2500 g | 27 (2.3) | 2.93 (0.83–10.40) | 1.56 (0.52–4.68) | 5.12 (1.92–13.64) | ||
| >=2500 g | 1175 (97.8) | 1.00 | 1.00 | 1.00 | ||
|
| ||||||
| (n = 1201) | Maternal history of asthma and allergic diseases | |||||
| Yes | 96 (8.0) | 2.38 (1.14–4.93) | 1.79 (1.01–3.18) | 2.31 (1.21–4.41) | ||
| No | 1105 (92.0) | 1.00 | 1.00 | 1.00 | ||
| (n = 1191) | Paternal history of asthma and allergic diseases | |||||
| Yes | 47 (4.0) | 0.74 (0.17–3.20) | 2.38 (1.13–5.04) | 3.48 (1.56–7.77) | ||
| No | 1144 (96.1) | 1.00 | 1.00 | 1.00 | ||
|
| ||||||
| (n = 1201) | Maternal education level | |||||
| College or university | 248 (20.6) | 2.51 (0.77–8.16) | 0.92 (0.49–1.74) | 0.90 (0.39–2.09) | ||
| High school | 399 (33.2) | 2.37 (0.77–7.27) | 0.71 (0.39–1.31) | 1.01 (0.47–2.13) | ||
| Secondary school | 403 (33.5) | 1.88 (0.62–5.72) | 0.66 (0.36–1.22) | 0.78 (0.37–1.64) | ||
| No or primary school | 152 (12.7) | 1.00 | 1.00 | 1.00 | ||
|
| ||||||
| Number of siblings | ||||||
| 3+ | 33 (2.8) | 2.34 (0.47–11.60) | NAb | 1.40 (0.36–5.48) | ||
| 2 | 112 (9.3) | 1.78 (0.61–5.21) | 0.40 (0.14–1.08) | 1.24 (0.51–3.02) | ||
| 1 | 781 (65.0) | 1.54 (0.75–3.14) | 1.51 (0.95–2.38) | 1.13 (0.63–2.02) | ||
| 0 | 276 (23.0) | 1.00 | 1.00 | 1.00 | ||
| Living in urban communes | ||||||
| Yes | 768 (63.9) | 1.20 (0.66–2.16) | 0.88 (0.60–1.30) | 1.43 (0.84–2.45) | ||
| No | 434 (36.1) | 1.00 | 1.00 | 1.00 | ||
| Smoker(s) in household | ||||||
| Yes | 685 (57.0) | 0.89 (0.52–1.52) | 1.05 (0.72–1.52) | 1.46 (0.89–2.39) | ||
| No | 517 (43.0) | 1.00 | 1.00 | 1.00 | ||
aOR, adjusted odds ratio; 95% CI, 95% confidence interval; NA, not applicable.
aA model incorporated sex, low birthweight, maternal and paternal asthma and allergic disease history, maternal educational level, number of siblings, living in urban area, and environmental tobacco smoke exposure.
bIt is not applicable because no children with current rhinoconjunctivitis had 3 or more siblings.
Odds ratios and adjusted odds ratios of asthma, rhinoconjunctivitis and eczema symptoms for birthweight, gestational age, and light-for-dates of the participating children.
| Characteristics | N | Cases | % | Asthma symptoms crude OR (95% CI) | Asthma symptoms adjusted ORa (95% CI) | Cases | % | Rhinoconjuncti-vitis symptoms crude OR (95% CI) | Rhinoconjuncti-vitis symptoms adjusted ORa (95% CI) | Cases | % | Eczema symptoms crude OR (95% CI) | Eczema symptoms adjusted ORa (95% CI) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||||||
| <2500 g | 27 | 3 | 11.1 | 2.41 (0.70–8.23) | 2.93 (0.83–10.40) | 4 | 14.8 | 1.35 (0.46–3.97) | 1.56 (0.52–4.69) | 6 | 22.2 | 4.25 (1.67–10.85) | 5.13 (1.93–13.62) |
| <= 2500 g | 1175 | 58 | 4.9 | 1.00 | 1.00 | 134 | 11.4 | 1.00 | 1.00 | 74 | 6.3 | 1.00 | 1.00 |
|
| |||||||||||||
| <2500 g | 27 | 3 | 11.1 | 2.42 (0.71–8.29) | 2.95 (0.83–10.46) | 4 | 14.8 | 1.33 (0.45–3.90) | 1.55 (0.51–4.64) | 6 | 22.2 | 4.44 (1.74–11.36) | 5.31 (2.00–14.12) |
| 2500–4000 g | 1141 | 56 | 4.8 | 1.00 | 1.00 | 132 | 11.6 | 1.00 | 1.00 | 69 | 6.1 | 1.00 | 1.00 |
| >4000 g | 34 | 2 | 5.8 | 1.21 (0.28–5.18) | 1.24 (0.28–5.38) | 2 | 5.9 | 0.48 (0.11–2.02) | 0.50 (0.11–2.15) | 5 | 14.7 | 2.68 (1.01–7.14) | 2.54 (0.92–6.98) |
|
| |||||||||||||
| <37 weeks (preterm) | 36 | 2 | 5.6 | 1.10 (0.26–4.70) | 1.14 (0.26–4.97) | 5 | 13.9 | 1.25 (0.48–3.28) | 1.45 (0.54–3.90) | 2 | 5.6 | 0.82 (0.19–3.48) | 0.84 (0.20–3.63) |
| >= 37 weeks | 1166 | 59 | 5.1 | 1.00 | 1.00 | 133 | 11.4 | 1.00 | 1.00 | 78 | 6.7 | 1.00 | 1.00 |
|
| |||||||||||||
| Light-for-dates | 129 | 6 | 3.9 | 0.73 (0.29–1.86) | 0.81 (0.31–2.08) | 10 | 7.8 | 0.62 (0.32–1.21) | 0.66 (0.33–1.30) | 9 | 7.0 | 1.06 (0.52–2.17) | 1.15 (0.55–2.40) |
| Appropriate/heavy-for-dates | 1073 | 56 | 5.2 | 1.00 | 1.00 | 128 | 11.9 | 1.00 | 1.00 | 71 | 6.6 | 1.00 | 1.00 |
|
| |||||||||||||
| High catch-up | 120 | 7 | 5.8 | 1.18 (0.52–2.65) | 1.25 (0.55–2.84) | 15 | 12.5 | 1.11 (0.63–1.97) | 1.09 (0.61–1.96) | 7 | 6.8 | 0.86 (0.38–1.90) | 0.83 (0.37–1.87) |
| Non high catch-up | 1082 | 54 | 5.0 | 1.00 | 1.00 | 123 | 11.4 | 1.00 | 1.00 | 73 | 5.8 | 1.00 | 1.00 |
OR, odds ratio; 95% CI, 95% confidence interval. aA model incorporated sex, one of anthropometric characteristics (Birthweight < 2500 g/ >= 2500 g, birthweight < 2500 g/ 2500–4000 g/ > 4000 g, preterm born, light-for-dates, or high catch-up in weight), maternal and paternal asthma and allergic disease history, maternal educational level, number of siblings, living in urban area, and environmental tobacco smoke exposure.